<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136247">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01327677</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00029336</org_study_id>
    <nct_id>NCT01327677</nct_id>
  </id_info>
  <brief_title>Safety Study of Analgesia After Craniotomy Surgery With End Tidal CO2 Monitoring</brief_title>
  <official_title>Post Craniotomy Analgesia Safety Monitoring With ET CO2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is being done to compare two methods of giving fentanyl, a narcotic often
      given to patients following brain surgery and determine if one method has more side effects
      than the other. Both of these methods are available in the postoperative treatment of pain.
      This research also is being done to determine if patients receiving narcotic pain medicine
      will benefit from additional monitoring of carbon dioxide levels. Since narcotic pain
      medicines can slow down breathing, we want to see if measuring exhaled carbon dioxide levels
      will help identify a slower breathing rate and improve safety.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      See brief summary
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory rate &lt; 10 breaths per minute for greater than 2 minutes.</measure>
    <time_frame>up to 24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>oxygen saturation &lt;90%, apnea &gt; 30 secs., ET CO2 &gt; 60, need for narcan, excessive somnolence</measure>
    <time_frame>up to 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">137</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>PRN fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A nurse can give the patient up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IVPCA fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fentanyl will be given with a Patient Controlled Analgesia (PCA) pump.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>25-50 mcg every 20 minutes</description>
    <arm_group_label>PRN fentanyl</arm_group_label>
    <other_name>Non applicable</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>20mcg/demand dose with an 8 minute lock out</description>
    <arm_group_label>IVPCA fentanyl</arm_group_label>
    <other_name>Non applicable</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male and female, English speaking patients undergoing supratentorial craniotomy
             for tumor under general anesthesia at the Johns Hopkins Hospital will be eligible for
             this study.

        Exclusion Criteria:

          -  pregnant women

          -  patients with post operative neurological changes

          -  patients who remain intubated post-operatively

          -  patients who require the use of concomitant administration of sedatives

               -  patients who are unable to initiate a PCA bolus

               -  patients who are unable to communicate verbally

               -  patients who are allergic to fentanyl

          -  patients who have a history of narcotic abuse

          -  patients who have a history of chronic pain requiring opioids

          -  patients who have been in any investigational drug trial within 1 month of the
             treatment day

          -  patients who have chronic respiratory insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Athir H Morad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 29, 2016</lastchanged_date>
  <firstreceived_date>March 25, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Athir Morad</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>pain management</keyword>
  <keyword>opioid analgesic therapy</keyword>
  <keyword>safety</keyword>
  <keyword>craniotomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
